NASDAQ: HCM
Hutchmed Ltd Stock Ownership - Who owns Hutchmed?

Insider buying vs selling

Have Hutchmed Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when HCM insiders and whales buy or sell their stock.

HCM Shareholders

What type of owners hold Hutchmed Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Schroder Investment Management Group0.34%2,923,667$39.24MInstitution
Allianz Asset Management Gmbh0.15%1,324,791$17.78MInstitution
State Street Corp0.04%349,524$4.69MInstitution
Aia Group Ltd0.04%315,439$4.23MInstitution
Millennium Management LLC0.04%309,977$4.16MInstitution
Mg PLC0.03%267,231$3.59MInstitution
Amundi0.02%173,894$2.33MInstitution
Acadian Asset Management LLC0.02%168,713$2.26MInstitution
Renaissance Technologies LLC0.02%159,300$2.14MInstitution
Catalyst Funds Management Pty Ltd0.02%142,231$1.91MInstitution

1 of 3

HCM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HCM0.83%0.00%
BHC69.27%30.71%Net SellingNet Buying
AMRX30.40%69.60%Net SellingNet Selling
SUPN46.43%53.57%Net SellingNet Selling
DVAX65.76%34.24%Net Selling

Hutchmed Stock Ownership FAQ

Who owns Hutchmed?

Hutchmed (NASDAQ: HCM) is owned by 0.83% institutional shareholders, 0.00% Hutchmed insiders, and 99.17% retail investors. Schroder Investment Management Group is the largest individual Hutchmed shareholder, owning 2.92M shares representing 0.34% of the company. Schroder Investment Management Group's Hutchmed shares are currently valued at $38.59M.

If you're new to stock investing, here's how to buy Hutchmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.